What Know About This Fund’s Exit From Ascendis Pharma
A notable fund liquidated its entire Ascendis Pharma stake, signaling a strategic rotation in a volatile biotech sect...
Identify the mix that offers broader exposure for retirement by comparing Sp500 and total market allocations and adjusting for risk.
28,595 articlesA notable fund liquidated its entire Ascendis Pharma stake, signaling a strategic rotation in a volatile biotech sect...
SpaceX plans a record-breaking IPO, but the bulk of proceeds is already spoken for. Analysts warn the small public fl...
Anthropic has confidentially filed its S-1, signaling a high-stakes move in the AI IPO race as investors weigh growth...
In Q1 2026, new homes held prices steady while resale values declined, signaling a pricing strategy where discounts r...
A new Nvidia platform called Vera Rubin could redefine AI economics for data centers. This piece breaks down what Ver...
Value stocks are resurging as inflation cools and markets favor durable cash flow. This piece examines why Vanguard M...
In June, SMCI faced a sharp 36% slide as investors weighed dilution, changing AI demand tides, and macro uncertainty....
A Parabilis Medicines director recently disclosed a substantial stake just after the company’s fresh IPO. This articl...
As AI hype cools, dividend-focused ETFs draw buyers seeking steadiness. HDV delivers a modest yield with a low fee an...
A discount retailer is stacking double-digit comps on top of double-digit comps. This article breaks down what that m...
When expenses shrink, choices grow. A lower cost of living can turn basic stability into genuine freedom—time for fam...
Weibo's Q1 2026 earnings transcript reveals a steady growth path with ad-driven strength and improving non-ad monetiz...